Iκb kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400

Molecular and Cellular Biology

Volumn 32, Issue 22, 2012, Pages 4684-4690

  Roget, Karine ^a   Ben Addi, Abduelhakem ^a   Mambole Dema, Agnes ^a   Gantke, Thorsten ^a   Yang, Huei Ting ^a   Janzen, Julia ^a   Morrice, Nick ^b   Abbott, Derek ^c   Ley, Steven C ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE; I KAPPA B KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; SERINE; TUMOR PROGRESSION LOCUS 2 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; I-KAPPA B KINASE; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE KINASE KINASES; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PLASMIDS; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SERINE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84868687471     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01065-12     Document Type: Article

References (39)

1. Aoki M, et al. 1993. The human cot proto-oncogene encodes two protein serine/threonine kinases with different transforming activities by alternative initiation of translation. J. Biol. Chem. 268:22723-22732.
2. Beinke S, Belich MP, Ley SC. 2002. The death domain of NF-κB1 p105 is essential for signal-induced p105 proteolysis. J. Biol. Chem. 277:24162- 24168.
3. Beinke S, et al. 2003. NF-κB p105 negatively regulates TPL-2 MEK kinase activity. Mol. Cell. Biol. 23:4739-4752.
4. Beinke S, et al. 2004. Lipopolysaccharide activation of the TPL-2/MEK/ extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Mol. Cell. Biol. 24:9658 -9667.
5. Belich MP, Salmeron A, Johnston LH, Ley SC. 1999. TPL-2 kinase regulates the proteolysis of the NF-κB inhibitory protein NF-κB1 p105. Nature 397:363-368.
6. Cho J, Melnick M, Solidakis GP, Tsichlis PN. 2005. Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an IκB kinase-β-dependent pathway and is required for Tpl2 activation by external signals. J. Biol. Chem. 280:20442-20448.
7. Clark K, et al. 2011. Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434:93-104.
8. Dumitru CD, et al. 2000. TNFα induction by LPS is regulated posttranscriptionally via a TPL2/ERK-dependent pathway. Cell 103:1071- 1083.
9. Eliopoulos AG, Wang C-C, Dumitru CD, Tsichlis PN. 2003. TPL-2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. EMBO J. 22:3855-3864.
10. Gantke T, Sriskantharajah S, Sadowski M, Ley SC. 2012. IκB kinase regulation of the TPL-2/ERK MAPK pathway. Immunol. Rev. 246:168- 182.
11. Handoyo H, et al. 2009. IRAK1-independent pathways required for the interleukin 1-stimulated activation of the TPL-2 catalytic subunit and its dissociation from ABIN-2. Biochem. J. 424:109 -118.
12. Hayden MS, Ghosh S. 2008. Shared principles in NF-κB signaling. Cell 132:344 -362.
13. Hutti JE, et al. 2004. A rapid method for determining protein kinase phosphorylation specificity. Nat. Methods 1:27-29.
14. Jia Y, et al. 2005. Purification and kinetic characterization of recombinant human mitogen-activated protein kinase kinase kinaseCOTand the complexes with its cellular partner NF-κB1 p105. Arch. Biochem. Biophys. 441:64 -74.
15. Kaiser F, et al. 2009. TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells. J. Exp. Med. 206:1863-1871.
16. Kanters E, et al. 2003. Inhibition of NF-κB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 112:1176 -1185.
17. Karin M, Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621- 663.
18. Karin M, Gallagher E. 2009. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol. Rev. 228:225-240.
19. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11:373- 384.
20. König R, et al. 2007. A probability-based approach for the analysis of large-scale RNAi screens. Nat. Methods 4:847- 849.
21. Kontoyiannis D, et al. 2002. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease. J. Exp. Med. 196:1563-1574.
22. Lang V, et al. 2003. βTrCP-mediated proteolysis of NF-κB1 p105 requires phosphorylation of p105 serines 927 and 932. Mol. Cell. Biol. 23: 402-413.
23. Lang V, et al. 2004. ABIN-2 forms a ternary complex with TPL-2 and NF-κB1 p105 and is essential for TPL-2 protein stability. Mol. Cell. Biol. 24:5235-5248.
24. Li X, Commane M, Jiang Z, Stark GR. 2001. IL-1-induced NF-kB and c-Jun N-terminal kinase (JNK) activation at IL-1 receptor-associated kinase (IRAK). Proc. Natl. Acad. Sci. U. S. A. 98:4461- 4465.
25. Lin X, Cunningham ET, Mu Y, Geleziunas R, Greene WC. 1999. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity 10:271-280.
26. Mielke LA, et al. 2009. Tumor progression locus 2 (Map3k8) is critical for host defense against Listeria monocytogenes and IL-1 production. J. Immunol. 183:7984 -7993.
27. Morita K-I, et al. 2001. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20:6028- 6036.
28. Papoutsopoulou S, et al. 2006. ABIN-2 is required for optimal activation of the TPL-2 / ERK MAP kinase pathway in innate immune responses. Nat. Immunol. 7:606-615.
29. Robinson MJ, Beinke S, Kouroumalis A, Tsichlis PN, Ley SC. 2007. Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages. Mol. Cell. Biol. 27:7355-7364.
30. Salmeron A, et al. 2001. Direct phosphorylation of NF-κB p105 by the IκB kinase complex on serine 927 is essential for signal-induced p105 proteolysis. J. Biol. Chem. 276:22215-22222.
31. Sha WC, Lious H-C, Tuomanen EI, Baltimore D. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
32. Smale ST. 2010. Selective transcription in response to an inflammatory stimulus. Cell 140:833- 844.
33. Sriskantharajah S, et al. 2009. Proteolysis of NF-κB1 p105 is essential for T cell antigen receptor-induced proliferation. Nat. Immunol. 10:38-47.
34. Symons A, Beinke S, Ley SC. 2006. MAP kinase kinase kinases and innate immunity. Trends Immunol. 27:40-48.
35. Warren MK, Vogel SN. 1985. Bone marrow-derived macrophages: development and regulation of differentiation markers by colonystimulating factor and interferons. J. Immunol. 134:982-989.
36. Waterfield M, Jin W, Reiley W, Zhang MY, Sun S-C. 2004. IKKβ is an essential component of the TPL-2 signaling pathway. Mol. Cell. Biol. 24: 6040-6048.
37. Waterfield MR, Zhang M, Norman LP, Sun S-C. 2003. NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the TPL-2 kinase. Mol. Cell 11:685- 694.
38. Yang HT, et al. 2012. Coordinate regulation of TPL-2 and NF-κB signaling in macrophages by NF-kB1 p105. Mol. Cell. Biol. 32:3438 -3451.
39. Yang HT, et al. 2011. NF-κB1 inhibits TLR-induced IFN-β production in macrophages through TPL-2-dependent ERK activation. J. Immunol. 186:1989 -1996.